Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study

Nanoscale, 2013, 5,12464-12473
DOI: 10.1039/C3NR04212J, Paper

Shengnan Yin, Zhiwei Li, Liang Cheng, Chao Wang, Yumeng Liu, Qian Chen, Hua Gong, Liang Guo, Yonggang Li, Zhuang Liu
A novel magnetic resonance contrast agent based on ultra-small Pt₃Co nanoparticles with high r₂ relaxivity is developed and used for in vivo tumor imaging.
The content of this RSS Feed (c) The Royal Society of Chemistry